Course Provider
Learning Objectives
Be familiar with how the mutations in bone marrow can change into leukemia cells.
Identify the biomarkers that can determine which treatment would be most effective for AML.
Be aware of the new targeted therapies to treat AML.
Recognize the role of FLT-3 inhibitors in AML treatment therapy.